Drug Profile
Research programme: immunological disorders therapy - Baylor Research Institute/Roche
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Baylor Research Institute; Roche
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Immunological disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Immunological-disorders in USA
- 07 Dec 2010 Early research in Immunological disorders in USA (unspecified route)